BCLI 外汇新闻
BrainStorm Cell Says FDA Meeting Provides Clear Path For Planned Phase 3b Trial Of NurOwn In ALS
BrainStorm Cell Therapeutics, Inc. (BCLI) announced Thursday the completion of a productive meeting with the U.S. Food and Drug Administration (FDA) to discuss NurOwn, its investigational treatment for amyotrophic lateral sclerosis (ALS).
RTTNews
|
426天前
BrainStorm Cell Therapeutics Promotes Stacy Lindborg To Work Alongside Chaim Lebovits As Co-CEO
Stem cell therapeutics developer BrainStorm Cell Therapeutics Inc. (BCLI) announced Wednesday the promotion of Stacy Lindborg to the role of Co-Chief Executive Officer. She will work alongside Chaim Lebovits, who is retaining his position as President and CEO.
RTTNews
|
763天前
